查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1611410

单细胞多组体学市场：按类型、技术、应用和最终用户划分 - 2025-2030 年全球预测

Single-Cell Multi-Omics Market by Type (Single Cell Genomics, Single Cell Metabolomics, Single Cell Proteomics), Technique (Single-Cell Analysis, Single-Cell Isolation & Dispensing), Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年单细胞多组体学市值为29.2亿美元，预计2024年将达到31.8亿美元，复合年增长率为10.65%，预计到2030年将达到59.3亿美元。

单细胞多组体学是一个新兴领域，透过在单细胞层级同时分析基因组、转录组、蛋白质组和表观基因讯息，在理解生物系统的复杂性方面具有巨大潜力。该技术在癌症研究、免疫学和个人化医疗等领域至关重要。对单细胞多组体学的需求源于提供单一细胞的详细分子蓝图的能力，使研究人员能够了解细胞异质性并可能彻底改变诊断和治疗方法，从而可以识别某些稀有细胞群。应用涵盖药物发现、生物标记识别和疾病途径分析等各个领域。受影响最大的最终用途领域包括製药公司、学术研究机构和生技公司。影响该市场的关键成长要素包括定序技术的进步、政府对基因组研究的资助增加以及对精准医疗的日益关注。在亚太地区等生物技术领域成长迅速的地区，成长机会尤其成熟，医疗基础设施的扩大和生物技术研究投资的增加预计将推动市场扩张。然而，市场面临高成本、资料解释复杂以及对先进生物资讯学能力的需求等挑战。为了充分利用潜在的商机，公司应专注于开发具有成本效益的解决方案，增强资料分析软体，并与学术和研究机构建立策略联盟。创新和研发领域包括提高单细胞多组体学平台的灵敏度和准确性、开发更有效的资料整合工具以及发现农业和环境科学的新应用。市场仍然充满活力和竞争，需要持续的技术进步和策略适应性，以满足不断变化的研究和临床需求。为了持续成长，我们也应该投资教育倡议，以提高人们对单细胞多体学在各个科学领域潜力的认识和理解。

主要市场统计
基准年[2023] 29.2亿美元
预计年份 [2024] 31.8亿美元
预测年份 [2030] 59.3亿美元
复合年增长率（%） 10.65%

市场动态：揭示快速发展的单细胞多组体学市场的关键市场洞察

单细胞多组体学市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球癌症和慢性病患者数量增加
    • 在单细胞体学中利用计算工具和生物资讯策略
    • 需要采用单细胞多组体学来加速药物发现和药物开发
  • 市场限制因素
    • 多组体学计划高成本且缺乏熟练人员
  • 市场机会
    • 在单细胞多组体学技术中采用人工智慧和机器学习
    • 表观基因、表观转录组和其他新体学的出现
  • 市场问题
    • 分析大型资料集的困难，对病患资料隐私的担忧

波特五力：驾驭单细胞多组体学市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解单细胞多组体学市场的外部影响

外部宏观环境因素在塑造单细胞多组体学市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解单细胞多组体学市场的竞争格局

对单细胞多组体学市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：单细胞多组体学市场供应商绩效评估

FPNV定位矩阵是评估单细胞多组体学市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製单细胞多组体学市场的成功之路

对于希望加强在全球市场的影响力的公司来说，单细胞多组体学市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境，主要企业的广泛资料，评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、主要产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地的癌症和慢性病病例正在增加
      • 利用计算工具和生物资讯策略进行单细胞体学
      • 需要采用单细胞多组体学来加速药物发现和开发
    • 抑制因素
      • 多体学计划高成本且缺乏熟练人员
    • 机会
      • 在单细胞多组体学技术中采用人工智慧和机器学习
      • 表观基因、表观转录组和其他新体学的出现
    • 任务
      • 难以分析大型资料集以及对病患​​资料隐私的担忧
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章单细胞多组体学市场：依类型

  • 介绍
  • 单细胞基因体学
  • 单细胞代谢体学
  • 单细胞蛋白质体学
  • 单细胞转录组学

第七章单细胞多组体学市场：依技术分类

  • 介绍
  • 单细胞分析
  • 单细胞分离与分配

第八章单细胞多组体学市场：依应用分类

  • 介绍
  • 细胞生物学
  • 免疫学
  • 神经病学
  • 肿瘤学
  • 干细胞研究

第 9 章 单细胞多组体学市场：依最终使用者分类

  • 介绍
  • 学术机构
  • 合约研究组织
  • 製药和生物技术公司

第十章美洲单细胞多组体学市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太单细胞多组体学市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的单细胞多组体学市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • 10x Genomics
  • Agilent Technologies, Inc.
  • Akoya Biosciences
  • Becton, Dickinson and Company
  • Berkeley Lights Inc.
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Cytena by Bico Group
  • Danaher Corporation
  • Dolomite Bio
  • Epicypher Inc.
  • Illumina, Inc
  • Merck KGaA
  • Miltenyi BIoTec BV & CO.
  • Mission Bio, Inc.
  • Nanostring Technologies, Inc.
  • Olink Holding AB
  • Parse Bioscience
  • Qiagen NV
  • Standard BioTools Inc.
  • Takara Holdings Inc.
  • Thermo Fisher Scientific Inc.
  • Vizgen Inc.
Product Code: MRR-7C31448F0BAB

The Single-Cell Multi-Omics Market was valued at USD 2.92 billion in 2023, expected to reach USD 3.18 billion in 2024, and is projected to grow at a CAGR of 10.65%, to USD 5.93 billion by 2030.

Single-cell multi-omics is an emerging field with significant potential in understanding the complexity of biological systems by simultaneously analyzing genomic, transcriptomic, proteomic, and epigenomic information at the single-cell level. This technique is critical in fields like cancer research, immunology, and personalized medicine. The necessity for single-cell multi-omics arises from its ability to provide a detailed molecular blueprint of individual cells, thus allowing researchers to comprehend cellular heterogeneity and identify rare cell populations, which could revolutionize diagnostics and therapeutics. Applications span across various segments, including drug discovery, biomarker identification, and disease pathway analysis. End-use sectors prominently impacted include pharmaceutical companies, academic research institutions, and biotechnology firms. Key growth factors influencing this market include advancements in sequencing technologies, increasing government funding for genomics research, and a rising focus on precision medicine. Opportunities for growth are particularly ripe in regions with burgeoning biotech sectors, like Asia-Pacific, where expanding healthcare infrastructure and growing investments in biotechnological research are expected to drive market expansion. However, the market faces challenges such as high costs associated with the technology, complex data interpretation, and the need for advanced bioinformatics capabilities. To capitalize on potential opportunities, companies should focus on developing cost-effective solutions, enhancing data analysis software, and forming strategic collaborations with academic and research institutions. Areas for innovation and research include improving the sensitivity and accuracy of single-cell multi-omics platforms, developing more effective data integration tools, and discovering novel applications in agriculture and environmental sciences. The market remains dynamic and highly competitive, necessitating continuous technological advancements and strategic adaptability to align with evolving research and clinical demands. For sustained growth, businesses should also invest in educational initiatives to increase awareness and understanding of the potential of single-cell multi-omics across various scientific sectors.

KEY MARKET STATISTICS
Base Year [2023] USD 2.92 billion
Estimated Year [2024] USD 3.18 billion
Forecast Year [2030] USD 5.93 billion
CAGR (%) 10.65%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Single-Cell Multi-Omics Market

The Single-Cell Multi-Omics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising number of cancer cases and chronic disorders globally
    • Utilization of computational tools and bioinformatics strategies for single-cell omics
    • Need for adoption of single-cell multi-omics to accelerate drug discovery and development
  • Market Restraints
    • High cost of multi-omics projects and lack of skilled personnel
  • Market Opportunities
    • Adoption of AI and ML in single-cell multi-omics technologies
    • Emergence of epigenome, epitranscriptome, and other new omics
  • Market Challenges
    • Difficult of analyzing large datasets and concerns associated with privacy of patient data

Porter's Five Forces: A Strategic Tool for Navigating the Single-Cell Multi-Omics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Single-Cell Multi-Omics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Single-Cell Multi-Omics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Single-Cell Multi-Omics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Single-Cell Multi-Omics Market

A detailed market share analysis in the Single-Cell Multi-Omics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Single-Cell Multi-Omics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Single-Cell Multi-Omics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Single-Cell Multi-Omics Market

A strategic analysis of the Single-Cell Multi-Omics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Single-Cell Multi-Omics Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Agilent Technologies, Inc., Akoya Biosciences, Becton, Dickinson and Company, Berkeley Lights Inc., BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., Bruker Corporation, Cytena by Bico Group, Danaher Corporation, Dolomite Bio, Epicypher Inc., Illumina, Inc, Merck KGaA, Miltenyi Biotec B.V. & CO., Mission Bio, Inc., Nanostring Technologies, Inc., Olink Holding AB, Parse Bioscience, Qiagen NV, Standard BioTools Inc., Takara Holdings Inc., Thermo Fisher Scientific Inc., and Vizgen Inc..

Market Segmentation & Coverage

This research report categorizes the Single-Cell Multi-Omics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Single Cell Genomics, Single Cell Metabolomics, Single Cell Proteomics, and Single Cell Transcriptomics.
  • Based on Technique, market is studied across Single-Cell Analysis and Single-Cell Isolation & Dispensing.
  • Based on Application, market is studied across Cell Biology, Immunology, Neurology, Oncology, and Stem Cell Research.
  • Based on End User, market is studied across Academic Institutes, Contract Research Organizations, and Pharmaceutical & Biotech Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of cancer cases and chronic disorders globally
      • 5.1.1.2. Utilization of computational tools and bioinformatics strategies for single-cell omics
      • 5.1.1.3. Need for adoption of single-cell multi-omics to accelerate drug discovery and development
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of multi-omics projects and lack of skilled personnel
    • 5.1.3. Opportunities
      • 5.1.3.1. Adoption of AI and ML in single-cell multi-omics technologies
      • 5.1.3.2. Emergence of epigenome, epitranscriptome, and other new omics
    • 5.1.4. Challenges
      • 5.1.4.1. Difficult of analyzing large datasets and concerns associated with privacy of patient data
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Single-Cell Multi-Omics Market, by Type

  • 6.1. Introduction
  • 6.2. Single Cell Genomics
  • 6.3. Single Cell Metabolomics
  • 6.4. Single Cell Proteomics
  • 6.5. Single Cell Transcriptomics

7. Single-Cell Multi-Omics Market, by Technique

  • 7.1. Introduction
  • 7.2. Single-Cell Analysis
  • 7.3. Single-Cell Isolation & Dispensing

8. Single-Cell Multi-Omics Market, by Application

  • 8.1. Introduction
  • 8.2. Cell Biology
  • 8.3. Immunology
  • 8.4. Neurology
  • 8.5. Oncology
  • 8.6. Stem Cell Research

9. Single-Cell Multi-Omics Market, by End User

  • 9.1. Introduction
  • 9.2. Academic Institutes
  • 9.3. Contract Research Organizations
  • 9.4. Pharmaceutical & Biotech Companies

10. Americas Single-Cell Multi-Omics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Single-Cell Multi-Omics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Single-Cell Multi-Omics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 10x Genomics
  • 2. Agilent Technologies, Inc.
  • 3. Akoya Biosciences
  • 4. Becton, Dickinson and Company
  • 5. Berkeley Lights Inc.
  • 6. BGI Genomics Co., Ltd.
  • 7. Bio-Rad Laboratories, Inc.
  • 8. Bruker Corporation
  • 9. Cytena by Bico Group
  • 10. Danaher Corporation
  • 11. Dolomite Bio
  • 12. Epicypher Inc.
  • 13. Illumina, Inc
  • 14. Merck KGaA
  • 15. Miltenyi Biotec B.V. & CO.
  • 16. Mission Bio, Inc.
  • 17. Nanostring Technologies, Inc.
  • 18. Olink Holding AB
  • 19. Parse Bioscience
  • 20. Qiagen NV
  • 21. Standard BioTools Inc.
  • 22. Takara Holdings Inc.
  • 23. Thermo Fisher Scientific Inc.
  • 24. Vizgen Inc.

LIST OF FIGURES

  • FIGURE 1. SINGLE-CELL MULTI-OMICS MARKET RESEARCH PROCESS
  • FIGURE 2. SINGLE-CELL MULTI-OMICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC SINGLE-CELL MULTI-OMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC SINGLE-CELL MULTI-OMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. SINGLE-CELL MULTI-OMICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. SINGLE-CELL MULTI-OMICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SINGLE-CELL MULTI-OMICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SINGLE-CELL MULTI-OMICS MARKET DYNAMICS
  • TABLE 7. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY SINGLE CELL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY SINGLE CELL METABOLOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY SINGLE CELL PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY SINGLE CELL TRANSCRIPTOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY SINGLE-CELL ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY SINGLE-CELL ISOLATION & DISPENSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY CELL BIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC SINGLE-CELL MULTI-OMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. SINGLE-CELL MULTI-OMICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 194. SINGLE-CELL MULTI-OMICS MARKET, FPNV POSITIONING MATRIX, 2023